Invesco Biotechnology & Genome ETF
Registrant
Invesco Exchange-Traded Fund Trust
Class ticker
Net Assets
$247,382,628
Holdings
30
Latest Report
Apr 30, 2026
Holdings · 30
Export CSV| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| United Therapeutics Corp. | UTHR | 27,212 | $15,547,576 | 6.28% | Long | EC | |
| Illumina, Inc. | ILMN | 104,832 | $13,286,408 | 5.37% | Long | EC | |
| Biogen Inc. | BIIB | 66,025 | $12,497,212 | 5.05% | Long | EC | |
| Incyte Corp. | INCY | 127,499 | $12,146,830 | 4.91% | Long | EC | |
| Alnylam Pharmaceuticals, Inc. | ALNY | 38,706 | $11,979,120 | 4.84% | Long | EC | |
| Regeneron Pharmaceuticals, Inc. | REGN | 16,684 | $11,796,589 | 4.77% | Long | EC | |
| Amgen Inc. | AMGN | 33,651 | $11,651,659 | 4.71% | Long | EC | |
| Gilead Sciences, Inc. | GILD | 87,264 | $11,417,622 | 4.62% | Long | EC | |
| BioCryst Pharmaceuticals, Inc. | BCRX | 923,458 | $8,458,875 | 3.42% | Long | EC | |
|
Catalyst Pharmaceuticals, Inc.
|
14888U101 | 290,513 | $8,172,131 | 3.30% | Long | EC | |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 110,374 | $8,110,282 | 3.28% | Long | EC | |
| Protagonist Therapeutics, Inc. | PTGX | 80,415 | $7,958,673 | 3.22% | Long | EC | |
| TG Therapeutics, Inc. | TGTX | 230,335 | $7,780,716 | 3.15% | Long | EC | |
| Royalty Pharma PLC | RPRX | 154,791 | $7,753,481 | 3.13% | Long | EC | |
| CareDx, Inc. | CDNA | 365,065 | $7,597,003 | 3.07% | Long | EC | |
| Neurocrine Biosciences, Inc. | NBIX | 53,660 | $7,065,412 | 2.86% | Long | EC | |
| Exelixis, Inc. | EXEL | 155,682 | $6,921,622 | 2.80% | Long | EC | |
| Bio-Techne Corp. | TECH | 122,004 | $6,749,261 | 2.73% | Long | EC | |
| PTC Therapeutics, Inc. | PTCT | 101,877 | $6,628,118 | 2.68% | Long | EC | |
| Veracyte, Inc. | VCYT | 196,903 | $6,482,047 | 2.62% | Long | EC | |
| Acadia Pharmaceuticals Inc. | ACAD | 285,787 | $6,415,918 | 2.59% | Long | EC | |
| Vericel Corp. | VCEL | 183,726 | $6,380,804 | 2.58% | Long | EC | |
| Halozyme Therapeutics, Inc. | HALO | 99,880 | $6,358,361 | 2.57% | Long | EC | |
| Repligen Corp. | RGEN | 52,183 | $6,173,771 | 2.50% | Long | EC | |
| Theravance Biopharma Inc. | TBPH | 368,704 | $6,172,105 | 2.49% | Long | EC | |
| Ionis Pharmaceuticals, Inc. | IONS | 82,240 | $6,148,262 | 2.49% | Long | EC | |
| BioMarin Pharmaceutical Inc. | BMRN | 112,225 | $6,050,050 | 2.45% | Long | EC | |
| Collegium Pharmaceutical, Inc. | COLL | 155,578 | $5,247,646 | 2.12% | Long | EC | |
| Qiagen N.V. | QGEN | 144,898 | $5,010,586 | 2.03% | Long | EC | |
| MannKind Corp. | MNKD | 1,268,504 | $3,589,866 | 1.45% | Long | EC |